Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01002010

CERILLIANT™ Suvorexant-D6 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco S1151ML

Catalog No. 01-002-010


Only null left
Add to Cart

Description

Description

Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia, approved for sale by the U.S. Food and Drug Administration (FDA) in 2014. The U.S. Drug Enforcement Administration (DEA) has scheduled this substance as controlled substance, as it may lead to physical or psychological dependence. This stable-labeled internal standard is suitable for use in quantitation of suvorexant levels by GC/MS or LC/MS for applications in clinical toxicology, therapeutic drug monitoring or urine drug testing.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

67-56-1
UN 1230 - class 3 - PG 2 - Methanol, solution
456.96
1 mL
C23H17D6ClN6O2
100 μg/mL in methanol
Ampule
9.7°C (49.5°F) - closed cup
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

H331-H370

H311

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

CERILLIANT is a registered trademark of Cerilliant Corporation